IGC Pharma (IGC) Receivables - Other (2016 - 2025)
IGC Pharma (IGC) has disclosed Receivables - Other for 15 consecutive years, with $670000.0 as the latest value for Q3 2025.
- Quarterly Receivables - Other fell 2.19% to $670000.0 in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $670000.0 through Sep 2025, down 2.19% year-over-year, with the annual reading at $680000.0 for FY2025, 0.87% down from the prior year.
- Receivables - Other for Q3 2025 was $670000.0 at IGC Pharma, down from $680000.0 in the prior quarter.
- The five-year high for Receivables - Other was $951000.0 in Q1 2023, with the low at $354000.0 in Q2 2022.
- Average Receivables - Other over 5 years is $647368.4, with a median of $680000.0 recorded in 2025.
- The sharpest move saw Receivables - Other surged 168.64% in 2023, then fell 28.22% in 2024.
- Over 5 years, Receivables - Other stood at $382000.0 in 2021, then skyrocketed by 96.6% to $751000.0 in 2022, then rose by 25.97% to $946000.0 in 2023, then dropped by 28.22% to $679000.0 in 2024, then decreased by 1.33% to $670000.0 in 2025.
- According to Business Quant data, Receivables - Other over the past three periods came in at $670000.0, $680000.0, and $680000.0 for Q3 2025, Q2 2025, and Q1 2025 respectively.